MBC BioLabs Overview

  • Investor Type
  • Accelerator/​Incubator

  • Status
  • Active

  • Investments
  • 48

  • Portfolio
  • 32

  • Exits
  • 13


MBC BioLabs General Information

Company Description

QB3@953 is a biotech incubator based in San Francisco, California. The firm provides incubator facilities which allow life science startups to progress at lightening speed, making a huge impact on the life-science ecosystem of the Bay Area.

Business Details

Formerly Known As
Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (415) 000-0000

MBC BioLabs Investments (48)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Siolta Therapeutics 12-Mar-2024 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
Cala Health 16-Nov-2021 00000 00000 0000 Therapeutic Devices Generating Revenue
Aptah Biosciences 26-Aug-2021 000000000000 Biotechnology Generating Revenue
AsherBio 23-Mar-2021 00000 00000 0000 Drug Discovery Generating Revenue
CHO Plus 01-Mar-2021 000000000000 Biotechnology Startup
BigHat Biosciences 15-Sep-2020 000000000000 Biotechnology Generating Revenue
Cleo Life Sciences 01-Sep-2019 000000000000 Consulting Services (B2B) Generating Revenue
ScalmiBio 03-May-2019 000000000000 Biotechnology Generating Revenue
Perlara 01-May-2019 Accelerator/Incubator Drug Discovery Generating Revenue
Deciduous Therapeutics 01-Mar-2019 Accelerator/Incubator Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 48 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MBC BioLabs Exits (13)

Company Name Exit Date Exit Type Exit Size
RubrYc Therapeutics 21-Sep-2022 Merger/Acquisition 000
ScalmiBio 04-Oct-2021 000000000000000000 00.00
Magnamosis 27-Sep-2021 000000000000000000
Scaled Biolabs 22-Aug-2021 000 00 00000000
Synimmune (Biotechnology) 25-May-2021 000 00 00000000
Control Panel 26-Apr-2021 000 00 00000000
Aether (Machinery (B2B)) 19-Feb-2021 000 00 00000000
Mattershift 01-Oct-2020 000 00 00000000
Blueprint Genetics 21-Jan-2020 Merger/Acquisition 00000
Bell Biosystems 01-Jun-2019 Out of Business
You’re viewing 10 of 13 exits. Get the full list »

MBC BioLabs Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

MBC BioLabs Management, Team & Partners (2)

Name Title Deals Funds Boards Office
Douglas Crawford Ph.D Founder & General Manager 0 San Francisco, CA
Peter Parker Executive 00 0 0 Cambridge, MA
To view MBC BioLabs’s complete team members history, request access »

MBC BioLabs Co-Investors (38)

Name With Exits Lead Partner Series Industry
Amgen 1 Series chart Industry bar
Ascension Ventures 0 0 Series chart Industry bar
Baird Capital 0 0 Series chart Industry bar
Magnetar Capital 0 0 Series chart Industry bar
The Invus Group 0 Series chart Industry bar
You’re viewing 5 of 38 co-investors. Get the full list »

MBC BioLabs FAQs

  • What is MBC BioLabs?

    QB3@953 is a biotech incubator based in San Francisco, California.

  • When was MBC BioLabs founded?

    MBC BioLabs was founded in 2013.

  • Who is the founder of MBC BioLabs?

    Douglas Crawford Ph.D is the founder of MBC BioLabs.

  • Where is MBC BioLabs headquartered?

    MBC BioLabs is headquartered in San Francisco, CA.

  • How many investments has MBC BioLabs made?

    MBC BioLabs has made 48 investments.

  • What has MBC BioLabs invested in?

    MBC BioLabs has made numerous investments in companies like Siolta Therapeutics, Cala Health, and Aptah Biosciences within the Drug Discovery, Therapeutic Devices, and Biotechnology industries.

  • What has MBC BioLabs invested in recently?

    MBC BioLabs's latest investment was on 12-Mar-2024 in Siolta Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »